4D Molecular Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
4D Molecular Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • 4D Molecular Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $118M, a 44.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $118M +$36.1M +44.3% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $81.4M +$31.2M +62.1% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $50.2M +$17.4M +53.1% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $32.8M +$12.5M +61.8% Dec 31, 2020 10-K 2022-03-28
Q4 2019 $20.3M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.